Modeling Human Protein Aggregation Cardiomyopathy Using Murine Induced Pluripotent Stem Cells
Authors:
Open Access
- 19 February 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 2 (3) , 161-166
Abstract
Several mutations in αB-crystallin (CryAB), a heat shock protein with chaperone-like activities, are causally linked to skeletal and cardiac myopathies in humans. To better understand the underlying pathogenic mechanisms, we had previously generated transgenic (TG) mice expressing R120GCryAB, which recapitulated distinguishing features of the myopathic disorder (e.g., protein aggregates, hypertrophic cardiomyopathy). To determine whether induced pluripotent stem cell (iPSC)-derived cardiomyocytes, a new experimental approach for human disease modeling, would be relevant to aggregation-prone disorders, we decided to exploit the existing transgenic mouse model to derive iPSCs from tail tip fibroblasts. Several iPSC lines were generated from TG and non-TG mice and validated for pluripotency. TG iPSC-derived cardiomyocytes contained perinuclear aggregates positive for CryAB staining, whereas CryAB protein accumulated in both detergent-soluble and insoluble fractions. iPSC-derived cardiomyocytes identified by cardiac troponin T staining were significantly larger when expressing R120GCryAB at a high level in comparison with TG low expressor or non-TG cells. Expression of fetal genes such as atrial natriuretic factor, B-type natriuretic peptide, and α-skeletal α-actin, assessed by quantitative reverse transcription-polymerase chain reaction, were increased in TG cardiomyocytes compared with non-TG, indicating the activation of the hypertrophic genetic program in vitro. Our study demonstrates for the first time that differentiation of R120G iPSCs into cardiomyocytes causes protein aggregation and cellular hypertrophy, recapitulating in vitro key pathognomonic hallmarks found in both animal models and patients. Our findings pave the way for further studies exploiting this cell model system for mechanistic and therapeutic investigations.Keywords
Funding Information
- National Institutes of Health (2R01-HL063834-06)
- National Institutes of Health (5R01-HL074370-03)
- National Institutes of Health (5DP1OD006438-03)
- American Heart Association (12P0ST9700016)
This publication has 15 references indexed in Scilit:
- Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated CardiomyopathyScience Translational Medicine, 2012
- Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In VitroCirculation Research, 2011
- Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature, 2011
- Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT SyndromeNew England Journal of Medicine, 2010
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndromeNature, 2010
- Nongenetic method for purifying stem cell–derived cardiomyocytesNature Methods, 2009
- Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in MiceCell, 2007
- Exercise reverses preamyloid oligomer and prolongs survival in αB-crystallin-based desmin-related cardiomyopathyProceedings of the National Academy of Sciences, 2007
- Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic miceOncogene, 2005
- Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in MiceCirculation Research, 2001